Next Issue
Volume 81, October
Previous Issue
Volume 81, June
 
 
arm-logo

Journal Browser

Journal Browser
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.

Adv. Respir. Med., Volume 81, Issue 5 (August 2013) – 11 articles , Pages 413-493

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
103 KiB  
Letter
Prof. Mieczysław Janowiec (1921–2012)—Obituary
by Zofia Zwolska
Adv. Respir. Med. 2013, 81(5), 492-493; https://doi.org/10.5603/ARM.35525 - 22 Aug 2013
Viewed by 188
Abstract
Mieczysław Janowiec urodził się 5 września w 1921 roku w Rabce [...] Full article
250 KiB  
Review
Primary Systemic ANCA-Associated Vasculitis—Recommendations Concerning Diagnosis and Treatment
by Elżbieta Wiatr and Dariusz Gawryluk
Adv. Respir. Med. 2013, 81(5), 479-491; https://doi.org/10.5603/ARM.35524 - 22 Aug 2013
Viewed by 253
Abstract
Pierwotne systemowe zapalenia naczyń (PZN) stanowią odrębną heterogenną grupę chorób o nieznanej etiologii [...] Full article
548 KiB  
Review
Long-Term Oxygen Therapy in Japan: History, Present Status, and Current Problems
by Kozui Kida, Takashi Motegi, Takeo Ishii and Kumiko Hattori
Adv. Respir. Med. 2013, 81(5), 468-478; https://doi.org/10.5603/ARM.35523 - 22 Aug 2013
Cited by 3 | Viewed by 367
Abstract
Historically, the progress of long term-oxygen therapy (LTOT) in Japan has been characterized by collaboration among academic groups, policy makers, and industrial companies. The public health insurance program has covered the cost of LTOT since 1985. Thomas Petty’s group in Denver enthusiastically carried [...] Read more.
Historically, the progress of long term-oxygen therapy (LTOT) in Japan has been characterized by collaboration among academic groups, policy makers, and industrial companies. The public health insurance program has covered the cost of LTOT since 1985. Thomas Petty’s group in Denver enthusiastically carried out the public implementation of LTOT and conveyed the concept of pulmonary rehabilitation for the processing with LTOT. Although the target diseases of LTOT in Japan tended to be chronic obstructive pulmonary disease or sequelae of primary lung tuberculosis, it was soon applied for cardiac diseases as well as other pulmonary diseases. Together with increasing medical costs for geriatric patients, the political conversion from hospital based care of a traditional style to home care system has been performed, with two background reasons: the improvement of quality of life of patients and the reduction of the medical expense. Presently, LTOT plays a pivotal role in the successful implementation of home respiratory care for elderly patients. In addition, this promotes comprehensive pulmonary rehabilitation, a team approach, and close liaisons between primary care and hospitals. Currently, the total number of patients using LTOT exceeds 150,000. In Japan, LTOT resulted in an advancement in the medical care as well as in administrative decision to introduce it as a nationwide system after analyzing the results of opinion polls of patients with respiratory failure. However, the recent great earthquake in East Japan revealed that many unresolved problems remain for these patients, and these issues are of great concern. Full article
237 KiB  
Case Report
Acute Lupus Pneumonitis—Case Report and Literature Review
by Małgorzata H. Starczewska, Liliana Wawrzyńska, Lucyna Opoka, Grzegorz Małek, Monika Wieliczko, Joanna Matuszkiewicz-Rowińska and Monika Szturmowicz
Adv. Respir. Med. 2013, 81(5), 460-467; https://doi.org/10.5603/ARM.35522 - 22 Aug 2013
Cited by 3 | Viewed by 295
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease that is characterized by its chronic course and the involvement of many organs and systems. The most common abnormality in the respiratory system of SLE patients is lupus pleuritis. Less common is parenchymal [...] Read more.
Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease that is characterized by its chronic course and the involvement of many organs and systems. The most common abnormality in the respiratory system of SLE patients is lupus pleuritis. Less common is parenchymal involvement, which may present as acute lupus pneumonitis (ALP) or chronic interstitial lung disease. Other possible pulmonary manifestations of SLE include pulmonary embolism, diffuse alveolar haemorrhage, acute reversible hypoxaemia, and shrinking lung syndrome. We present the case report of a young woman with previously diagnosed membranous glomerulonephritis with nephrotic syn- drome and antiphospholipid syndrome, who was admitted with marked of shortness of breath. The diagnostic process, including imaging studies and laboratory tests, enabled us to confirm a diagnosis of ALP. After initiation of treatment with high doses of methyloprednisolone, nearly complete remission of pulmonary changes was observed. We also perform a literature review regarding acute lupus pneumonitis. Full article
329 KiB  
Case Report
Interstitial Pneumonia Connected with Rituximab Therapy—Case Report
by Dorota Wyrostkiewicz, Wojciech Skorupa, Inga Barańska and Jan Kuś
Adv. Respir. Med. 2013, 81(5), 453-459; https://doi.org/10.5603/ARM.35521 - 22 Aug 2013
Viewed by 201
Abstract
Rituximab (RTX) is a monoclonal antibody against the CD20 antigen found on the surface of B cells. RTX causes cell lysis and is therefore used to treat lymphomas, leukaemias, transplant rejection and certain autoimmune disorders. Pulmonary adverse events associated with RTX have been [...] Read more.
Rituximab (RTX) is a monoclonal antibody against the CD20 antigen found on the surface of B cells. RTX causes cell lysis and is therefore used to treat lymphomas, leukaemias, transplant rejection and certain autoimmune disorders. Pulmonary adverse events associated with RTX have been reported in literature. We describe a patient with follicular lymphoma treated with R-CHOP scheme (rituximab, cyclophosphamide, doxorubicin, vincri- stine, prednisone) who had pulmonary symptoms during chemotherapy which were diagnosed as rituximab-induced interstitial pneumonia. Symptoms and radiological changes resolved with prednisone therapy. Full article
210 KiB  
Case Report
Lipoid Pneumonia—A Case of Refractory Pneumonia in a Child Treated with Ketogenic Diet
by Piotr Buda, Anna Wieteska-Klimczak, Anna Własienko, Agnieszka Mazur, Jerzy Ziołkowski, Joanna Jaworska, Andrzej Kościesza, Dorota Dunin-Wąsowicz and Janusz Książyk
Adv. Respir. Med. 2013, 81(5), 448-452; https://doi.org/10.5603/ARM.35520 - 22 Aug 2013
Cited by 3 | Viewed by 352
Abstract
Lipoid pneumonia (LP) is a chronic inflammation of the lung parenchyma with interstitial involvement due to the accumulation of endoge- nous or exogenous lipids. Exogenous LP (ELP) is associated with the aspiration or inhalation of oil present in food, oil-based medications or radiographic [...] Read more.
Lipoid pneumonia (LP) is a chronic inflammation of the lung parenchyma with interstitial involvement due to the accumulation of endoge- nous or exogenous lipids. Exogenous LP (ELP) is associated with the aspiration or inhalation of oil present in food, oil-based medications or radiographic contrast media. The clinical manifestations of LP range from asymptomatic cases to severe pulmonary involvement, with respiratory failure and death, according to the quantity and duration of the aspiration. The diagnosis of exogenous lipoid pneumonia is based on a history of exposure to oil and the presence of lipid-laden macrophages on sputum or bronchoalveolar lavage (BAL) analysis. High-resolution computed tomography (HRCT) is the imaging technique of choice for evaluation of patients with suspected LP. The best therapeutic strategy is to remove the oil as early as possible through bronchoscopy with multiple BALs and interruption in the use of mineral oil. Steroid therapy remains controversial, and should be reserved for severe cases. We describe a case of LP due to oil aspiration in 3-year-old girl with intractable epilepsy on ketogenic diet. Diagnostic problems were due to non-specific symptoms that were mimicing serious infectious pneumonia. A high index of suspicion and precise medical history is required in cases of refractory pneumonia and fever unresponsive to conventional therapy. Gastroesophageal reflux and a risk of aspiration may be regarded as relative contraindications to the ketogenic diet. Conservative treatment, based on the use of oral steroids, proved to be an efficient therapeutic approach in this case. Full article
272 KiB  
Article
Talc Slurry Pleurodesis via Chest Tube in Department of Pulmonology—A 24-Case Study
by Grzegorz Gawron, Jacek Gabryś and Adam Barczyk
Adv. Respir. Med. 2013, 81(5), 439-447; https://doi.org/10.5603/ARM.35519 - 22 Aug 2013
Cited by 1 | Viewed by 261
Abstract
Introduction: Chemical pleurodesis is an accepted palliative therapy for patients with recurrent and symptomatic pleural effusion. The aim of the study is to present our own experiences with a less invasive variant of this procedure performed with talc slurry administered via a [...] Read more.
Introduction: Chemical pleurodesis is an accepted palliative therapy for patients with recurrent and symptomatic pleural effusion. The aim of the study is to present our own experiences with a less invasive variant of this procedure performed with talc slurry administered via a chest tube under local anaesthesia. Available medical literature in Polish does not contain information about this type of pleurodesis. Materials and Methods: During 2005–2011 in the Pulmonology and Respiratory Rehabilitation Department we hospitalized and diagnosed 162 patients with pleural fluid. Pleurodesis was performed in 24 patients (14.8%) with persistent pleural fluid. In this article we present retrospective analysis of safety, efficacy of treatment and patients’ survival time. We also provide detailed information about this type of pleurodesis: clinical theory, indications, contraindications, patient’s preparation, description of procedure with our modifications and use of chest X-ray and transthoracic ultrasound. Results: The procedure was effective in 20 cases, partially effective in 3 cases and ineffective in one case. In-hospital mortality was 4.2% (one case). We frequently observed mild fever and local pain. Median hospitalization was 9 days. Median survival time was 32 days, whereas in the group of still living patients it was 96 days. Conclusions: Talc slurry pleurodesis with adequate patient preselection is a relatively effective and safe procedure. The procedure can be performed in a non-surgical pulmonology unit. Full article
240 KiB  
Article
A Retrospective Study of Hospitalized Pneumonia in Two Polish Counties (2006–2008)
by Rafal Harat, Grzegorz Górny, Lindsay Jorgensen, Justyna Pluta, Sharon Gray, Nathalie Dartois, Jian Ye and Elane M. Gutterman
Adv. Respir. Med. 2013, 81(5), 429-438; https://doi.org/10.5603/ARM.35518 - 22 Aug 2013
Cited by 1 | Viewed by 269
Abstract
Introduction: In Poland, multi-cause pneumonia is not well characterized, and there is limited pneumococcal vaccination in the youngest and oldest age groups. The goal of this study was to assess hospitalized pneumonia across all age groups in two Polish counties. Material and [...] Read more.
Introduction: In Poland, multi-cause pneumonia is not well characterized, and there is limited pneumococcal vaccination in the youngest and oldest age groups. The goal of this study was to assess hospitalized pneumonia across all age groups in two Polish counties. Material and methods: Using electronic administrative databases, cases were identified as county residents hospitalized at Chrzanów and Inowrocław County Hospitals from 2006–2008, assigned a diagnosis of pneumonia. Calculations by admission year, sex, and age category were: hospitalization rates per 1000 persons; in-hospital mortality rates per 100 persons; and median length of stay (LOS). Results: There were 1444 and 2956 hospitalizations for new episodes of pneumonia with rates of 3.76 (95% confidence interval [CI] 3.57–3.96) and 5.99 (95% CI 5.77–6.21) per 1000 persons in Chrzanów and Inowrocław counties, respectively. In combined data, the highest hospitalization rate was among patients aged 0–4 years (30.77; 95% CI 29.06–32.55) followed by those aged ≥ 75 years (25.39; 95% CI 24.01–26.83). In-hospital mortality rates increased with age at both sites. The median LOS was 8 days. Conclusions: Pneumonia hospitalizations were substantial, especially for the youngest and oldest age groups. Future public health interventions aimed at these age groups might improve disease outlook. Full article
240 KiB  
Article
Diagnostic Potential of Contrast-Enhanced Ultrasound (CEUS) In the Assessment of Spleen and Liver Granulomas in the Course of Sarcoidosis
by Piotr Grzelak, Łukasz Augsburg, Agata Majos, Ludomir Stefańczyk, Paweł Górski, Wojciech Piotrowski and Adam Antczak
Adv. Respir. Med. 2013, 81(5), 424-428; https://doi.org/10.5603/ARM.35517 - 22 Aug 2013
Cited by 1 | Viewed by 271
Abstract
Introduction: The aim of this study was to analyze the diagnostic potential of contrast enhanced ultrasound (CEUS) for the recognition of focal lesions of the spleen and liver in patients suffering from sarcoidosis. Material and methods: We analyzed the outcome of [...] Read more.
Introduction: The aim of this study was to analyze the diagnostic potential of contrast enhanced ultrasound (CEUS) for the recognition of focal lesions of the spleen and liver in patients suffering from sarcoidosis. Material and methods: We analyzed the outcome of diagnostic imaging in a group of 21 patients treated for pulmonary sarcoidosis, searching for the systemic infiltration of the liver and/or spleen. All the participants are patients with inactive disease, who are monitored every 6 months at the Pulmonology Clinic. Apart from the check-up high-resolution computed tomography (HR-CT)—every 2 years, patients underwent an initial ultrasound examination (US) and if there was a suspicion of systemic infiltration, abdominal CT and/or magnetic resonance imaging (MRI) and CEUS were performed. Results: In 18 patients suffering from pulmonary sarcoidosis diagnostic imaging revealed no systemic infiltration. In three patients, the use of CEUS exposed the presence of lesions in the parenchymal organs. In all cases, the images from CEUS were consistent with those from CT/MRI. Conclusions: CEUS has the potential to become a reliable and safe screening tool for systemic infiltration in patients with sarcoidosis. It may also be an important method of monitoring the effects of therapy. Full article
197 KiB  
Article
Prevalence of Metabolic Syndrome Diagnosis in Patients with Obstructive Sleep Apnoea Syndrome According to Adopted Definition
by Marta Kumor, Piotr Bielicki, Małgorzata Barnaś, Tadeusz Przybyłowski, Jan Zieliński and Ryszarda Chazan
Adv. Respir. Med. 2013, 81(5), 417-423; https://doi.org/10.5603/ARM.35515 - 22 Aug 2013
Cited by 1 | Viewed by 245
Abstract
Introduction: Metabolic syndrome (MS), which is connected with enlarged cardiovascular risk, is common in patients with OSAS. The aim of the study was to estimate the prevalence of MS in patients with OSAS according to two definitions of MS (criteria from NCEP-ATP [...] Read more.
Introduction: Metabolic syndrome (MS), which is connected with enlarged cardiovascular risk, is common in patients with OSAS. The aim of the study was to estimate the prevalence of MS in patients with OSAS according to two definitions of MS (criteria from NCEP-ATP III from 2001 versus criteria from IDF 2005). Material and methods: Materials consisted of 155 males and 18 females with OSAS (mean AHI 44 ± 22 h−1), obesity (BMI 31.8 ± 5.0 kg/m2), aged 53.9 ± 9.3 years (mean ± SD). Serum lipids, glucose, body mass index (BMI), waist circumference (WC) and waist-to-hip ratio (WHR) were measured in all patients. Results: According to first definition (NCEP—ATP III from 2001), MS was diagnosed in 98 patients (56% of the whole group—MS1 group) compared to 120 patients (69% of the whole group—MS2 group) diagnosed according to the second definition (IDF from 2005), p < 0.05. No differences in BMI and WC between the groups were found. Significant differences in WHR were noted (MS1 group: 1.005 ± 0.05 vs. MS2 group: 1.027 ± 0.06, p < 0.05). Patients from the MS2 group had higher cholesterol HDL compared to the MS1 group (52.3 ± 12.1 mg/dl vs. 42.3 ± 12.1 mg/dl, p < 0.05). Serum triglyceride concentrations were significantly higher in the MS1 group than in the MS2 group (228 ± 122 mg/dl vs. 122 ± 49 mg/dl, p < 0.05). There were no differences in OSAS severity between the MS1 and MS2 group. In both groups weak correlations between diagnosis of MS and AHI were f ound (r = 0.19 for MS1 and r = 0.21 for MS2, p < 0.05) They are, however, clinically insignificant. Conclusions: The IDF definition from 2005 of metabolic syndrome indeed increases the frequency of diagnosis of metabolic syndrome in patients with OSAS. We did not observe essential clinical correlation among the degree of OSAS severity and recognition of metabolic syndrome in the MS1 or in the MS2 group. Full article
129 KiB  
Editorial
Związek Pomiędzy Obturacyjnym Bezdechem Sennym a Zespołem Metabolicznym
by Andrzej Januszewicz, Aleksander Prejbisz and Elżbieta Florczak
Adv. Respir. Med. 2013, 81(5), 413-416; https://doi.org/10.5603/ARM.35514 - 22 Aug 2013
Viewed by 205
Abstract
Na przestrzeni ostatniej dekady przedmiotem rosnącego zainteresowania i badań klinicznych pozostaje związek pomiędzy obturacyjnym bez-dechem sennym (OBS) a zespołem metabolicz-nym (ZM) [...] Full article
Previous Issue
Next Issue
Back to TopTop